Rhythm Pharmaceuticals Stock Price Prediction

RYTM Stock  USD 40.98  0.45  1.09%   
As of now, the RSI of Rhythm Pharmaceuticals' share price is approaching 39 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Rhythm Pharmaceuticals, making its price go up or down.

Oversold Vs Overbought

39

 
Oversold
 
Overbought
Rhythm Pharmaceuticals stock price prediction is an act of determining the future value of Rhythm Pharmaceuticals shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Rhythm Pharmaceuticals' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Rhythm Pharmaceuticals and does not consider all of the tangible or intangible factors available from Rhythm Pharmaceuticals' fundamental data. We analyze noise-free headlines and recent hype associated with Rhythm Pharmaceuticals, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Rhythm Pharmaceuticals' stock price prediction:
EPS Estimate Next Quarter
(0.70)
EPS Estimate Current Year
(4.14)
EPS Estimate Next Year
(2.07)
Wall Street Target Price
59
Quarterly Revenue Growth
1.757
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Rhythm Pharmaceuticals based on different types of headlines from major news networks to social media. The Rhythm stock price prediction module provides an analysis of price elasticity to changes in media outlook on Rhythm Pharmaceuticals over a specific investment horizon. Using Rhythm Pharmaceuticals hype-based prediction, you can estimate the value of Rhythm Pharmaceuticals from the perspective of Rhythm Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Rhythm Pharmaceuticals using Rhythm Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Rhythm using crowd psychology based on the activity and movement of Rhythm Pharmaceuticals' stock price.

Rhythm Pharmaceuticals Short Interest

A significant increase or decrease in Rhythm Pharmaceuticals' short interest from the previous month could be a good indicator of investor sentiment towards Rhythm. Short interest can provide insight into the potential direction of Rhythm Pharmaceuticals stock and how bullish or bearish investors feel about the market overall. An investor who is long Rhythm Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Rhythm Pharmaceuticals and may potentially protect profits, hedge Rhythm Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA
34.1432
Short Percent
0.2723
Short Ratio
16.58
Shares Short Prior Month
9.7 M
50 Day MA
41.1676

Rhythm Pharmaceuticals Hype to Price Pattern

Investor biases related to Rhythm Pharmaceuticals' public news can be used to forecast risks associated with an investment in Rhythm. The trend in average sentiment can be used to explain how an investor holding Rhythm can time the market purely based on public headlines and social activities around Rhythm Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Rhythm Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Rhythm Pharmaceuticals.

Rhythm Pharmaceuticals Implied Volatility

    
  81.21  
Rhythm Pharmaceuticals' implied volatility exposes the market's sentiment of Rhythm Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Rhythm Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Rhythm Pharmaceuticals stock will not fluctuate a lot when Rhythm Pharmaceuticals' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Rhythm Pharmaceuticals. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Rhythm Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Rhythm because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Rhythm Pharmaceuticals after-hype prediction price

    
  USD 40.74  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Rhythm Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rhythm Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
34.4737.6045.08
Details
Naive
Forecast
LowNextHigh
40.7243.8546.99
Details
9 Analysts
Consensus
LowTargetHigh
37.1140.7845.27
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-2.41-2.16-0.61
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Rhythm Pharmaceuticals. Your research has to be compared to or analyzed against Rhythm Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Rhythm Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Rhythm Pharmaceuticals.

Rhythm Pharmaceuticals After-Hype Price Prediction Density Analysis

As far as predicting the price of Rhythm Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Rhythm Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Rhythm Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Rhythm Pharmaceuticals Estimiated After-Hype Price Volatility

In the context of predicting Rhythm Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Rhythm Pharmaceuticals' historical news coverage. Rhythm Pharmaceuticals' after-hype downside and upside margins for the prediction period are 37.61 and 43.87, respectively. We have considered Rhythm Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
40.98
40.74
After-hype Price
43.87
Upside
Rhythm Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Rhythm Pharmaceuticals is based on 3 months time horizon.

Rhythm Pharmaceuticals Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Rhythm Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rhythm Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Rhythm Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.14 
3.13
  0.24 
  0.01 
10 Events / Month
2 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
40.98
40.74
0.59 
183.04  
Notes

Rhythm Pharmaceuticals Hype Timeline

Rhythm Pharmaceuticals is at this time traded for 40.98. The entity has historical hype elasticity of -0.24, and average elasticity to hype of competition of -0.01. Rhythm is anticipated to decline in value after the next headline, with the price expected to drop to 40.74. The average volatility of media hype impact on the company price is about 183.04%. The price decrease on the next news is expected to be -0.59%, whereas the daily expected return is at this time at -0.14%. The volatility of related hype on Rhythm Pharmaceuticals is about 6260.0%, with the expected price after the next announcement by competition of 40.97. About 99.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 0.75. Rhythm Pharmaceuticals recorded a loss per share of 3.2. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days.
Check out Rhythm Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.

Rhythm Pharmaceuticals Related Hype Analysis

Having access to credible news sources related to Rhythm Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Rhythm Pharmaceuticals' future price movements. Getting to know how Rhythm Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Rhythm Pharmaceuticals may potentially react to the hype associated with one of its peers.

Rhythm Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Rhythm price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rhythm using various technical indicators. When you analyze Rhythm charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Rhythm Pharmaceuticals Predictive Indicators

The successful prediction of Rhythm Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Rhythm Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Rhythm Pharmaceuticals based on analysis of Rhythm Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Rhythm Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Rhythm Pharmaceuticals's related companies.
 2022 2023 2024 (projected)
Payables Turnover0.441.92.0
Days Of Inventory On Hand499.16338.4241.38

Story Coverage note for Rhythm Pharmaceuticals

The number of cover stories for Rhythm Pharmaceuticals depends on current market conditions and Rhythm Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Rhythm Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Rhythm Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Rhythm Pharmaceuticals Short Properties

Rhythm Pharmaceuticals' future price predictability will typically decrease when Rhythm Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Rhythm Pharmaceuticals often depends not only on the future outlook of the potential Rhythm Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rhythm Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding57.7 M
Cash And Short Term Investments275.8 M
When determining whether Rhythm Pharmaceuticals is a strong investment it is important to analyze Rhythm Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Rhythm Pharmaceuticals' future performance. For an informed investment choice regarding Rhythm Stock, refer to the following important reports:
Check out Rhythm Pharmaceuticals Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Rhythm Stock, please use our How to Invest in Rhythm Pharmaceuticals guide.
You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Complementary Tools for Rhythm Stock analysis

When running Rhythm Pharmaceuticals' price analysis, check to measure Rhythm Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rhythm Pharmaceuticals is operating at the current time. Most of Rhythm Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rhythm Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rhythm Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rhythm Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Stocks Directory
Find actively traded stocks across global markets
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Is Rhythm Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Rhythm Pharmaceuticals. If investors know Rhythm will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Rhythm Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.20)
Revenue Per Share
1.343
Quarterly Revenue Growth
1.757
Return On Assets
(0.32)
Return On Equity
(0.85)
The market value of Rhythm Pharmaceuticals is measured differently than its book value, which is the value of Rhythm that is recorded on the company's balance sheet. Investors also form their own opinion of Rhythm Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Rhythm Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Rhythm Pharmaceuticals' market value can be influenced by many factors that don't directly affect Rhythm Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Rhythm Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Rhythm Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Rhythm Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.